Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%
Look for Shares of ResMed to Potentially Pullback after Yesterday's 6.25% Rise

Print Share

Jan 25, 2013 (SmarTrend(R) News Watch via COMTEX) -- ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $46.86 to a high of $48.47. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of $45.62 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

In the past 52 weeks, shares of ResMed have traded between a low of $26.03 and a high of $48.47 and are now at $48.31, which is 86% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.6% while the 50-day MA has advanced 0.6%.

SmarTrend recommended that subscribers consider buying shares of ResMed on August 3rd, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $35.25. Since that recommendation, shares of ResMed have risen 29.0%. We continue to monitor RMD for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at cbrian@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

Copyright, Comtex News Network, Inc. 2013

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.